Blood Research

Cited by CrossRef (12)

  1. Mariola Rychlik-Sych, Małgorzata Barańska, Michał Dudarewicz, Jadwiga Skrętkowicz, Agnieszka Żebrowska, Anna Woźniacka, Jacek Owczarek, Daria Orszulak-Michalak, Elżbieta Waszczykowska. Haplotypes of ABCB1 1236C >T (rs1128503), 2677G >T/A (rs2032582), and 3435C >T (rs1045642) in patients with bullous pemphigoid. Arch Dermatol Res 2018;310:515
    https://doi.org/10.1007/s00403-018-1842-8
  2. Jie-Ru Chen, Xiu-Hong Jia, Hong Wang, Ying-Jie Yi, You-Jie Li. With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells. 2017;37:2735
    https://doi.org/10.3892/or.2017.5535
  3. Tânia P. Almeida, Alice A. Ramos, Joana Ferreira, Amaya Azqueta, Eduardo Rocha. Bioactive Compounds from Seaweed with Anti-Leukemic Activity: A Mini-Review on Carotenoids and Phlorotannins. MRMC 2020;20:39
    https://doi.org/10.2174/1389557519666190311095655
  4. Tsuyoshi Aoyama, Yoshihiko Shibayama, Tatsuhiko Furukawa, Mitsuru Sugawara, Yoh Takekuma. Continuous Cytostatic Effects of BCR-ABL Tyrosine Kinase Inhibitors (TKIs) after Washout in Human Leukemic K562 Cells. Biological & Pharmaceutical Bulletin 2019;42:1805
    https://doi.org/10.1248/bpb.b19-00185
  5. Guangli Yin, Zhengrui Xiao, Ying Ni, Xiaoyan Qu, Hanxin Wu, Hua Lu, Sixuan Qian, Lijuan Chen, Jianyong Li, Hairong Qiu, Kourong Miao. Association of MDR1 single-nucleotide polymorphisms and haplotype variants with multiple myeloma in Chinese Jiangsu Han population. Tumor Biol. 2016;37:9549
    https://doi.org/10.1007/s13277-015-4574-9
  6. . .
    https://doi.org/
  7. Negar Nouri, Valiollah Mehrzad, Zahra Khalaj, Erfan Zaker, Fateme Zare, Elham Abbasi, Maede Khosravi, Seyed Mehdi Kalantar, Mansoor Salehi. Effects of ABCG2 C421A and ABCG2 G34A genetic polymorphisms on clinical outcome and response to imatinib mesylate, in Iranian chronic myeloid leukemia patients. Egypt J Med Hum Genet 2023;24
    https://doi.org/10.1186/s43042-022-00379-6
  8. Alberto Lazarowski. Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy. 2023.
    https://doi.org/10.1016/B978-0-12-816434-1.00006-1
  9. Sara Galimberti, Cristina Bucelli, Elena Arrigoni, Claudia Baratè, Susanna Grassi, Federica Ricci, Francesca Guerrini, Elena Ciabatti, Carmen Fava, Antonio D’Avolio, Giulia Fontanelli, Giovanna Rege Cambrin, Alessandro Isidori, Federica Loscocco, Giovanni Caocci, Marianna Greco, Monica Bocchia, Lara Aprile, Antonella Gozzini, Barbara Scappini, Daniele Cattaneo, Anna Rita Scortechini, Giorgio La Nasa, Alberto Bosi, Pietro Leoni, Romano Danesi, Giuseppe Saglio, Giuseppe Visani, Agostino Cortelezzi, Mario Petrini, Alessandra Iurlo, Antonello Di Paolo. The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia. Oncotarget 2017;8:88021
    https://doi.org/10.18632/oncotarget.21406
  10. A. S. Gorbenko, I. A. Olkhovskiy, M. A. Mikhalev, E. V. Vasiliev, V. V. Ovsyannikova, T. I. Olhovik, A. S. Hazieva, M. A. Stolyar. A study of the association of C3435T polymorphism of MDR1 gene and its mRNA expression with the level of daunorubicin accumulation in leukocytes in patients with chronic myeloproliferative diseases. Lab. sluzh. 2018;7:13
    https://doi.org/10.17116/labs2018703113
  11. Islem Ben Hassine, Hanene Gharbi, Ismail Soltani, Hind Ben Hadj Othman, Ahlem Farrah, Hassiba Amouri, Mouheb Teber, Hela Ghedira, Yosra Ben Youssef, Ines Safra, Salem Abbes, Samia Menif. Molecular study of ABCB1 gene and its correlation with imatinib response in chronic myeloid leukemia. Cancer Chemother Pharmacol 2017;80:829
    https://doi.org/10.1007/s00280-017-3424-4
  12. Fatemeh Mohammadi, Mohammad Shafiei, Dlnya Assad, Golale Rostami, Mohammad Hamid, Ali Mohammad Foroughmand. Impact of ABCB1 Gene Polymorphisms and Smoking on the Susceptibility Risk of Chronic Myeloid Leukemia and Cytogenetic Response. ibj 2021;25:54
    https://doi.org/10.29252/ibj.25.1.54
© 2024. BLOOD RESEARCH All rights reserved. Powered by INFOrang Co., Ltd